China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

“Additive manufacturing has made its way into our healthcare system,” says Mark Wehde of Mayo Clinic Division of Engineering

Wearable technologies could help address some of our greatest healthcare unmet needs, says Maria Shepherd of Medi-Vantage. While “wearable medical technology is in its infancy,

“2019 was really the year of connected care/digital health—and there’s so much more to come,”

One of the biggest deals in diagnostics this year could be in the process of unfolding, according to a report from Bloomberg. The media outlet is reporting that Thermo Fisher Scientific has approached Qiagen to acquire it in a deal valued at

A common cardiac blood test done before surgery can predict who will experience adverse outcomes after most types of surgery, said researchers from Hamilton Health Sciences.

DiaSorin Molecular has received US Food and Drug Administration clearance for its Simplexa VZV Swab Direct assay to detect varicella-zoster virus (VZV) DNA from cutaneous and mucocutaneous swab specimens, the firm announced recently.

LifeVault Bio, a consumer-facing company offering personal biobanking services under the name GoodCell, said recently that it has closed on $5.6 million in financing. That total includes $2.6 million in investments and a $3 million convertib

Grail has raised $125 million out of a planned $250 million equity financing offering, according to a recently filed Form D notice with the US Securities and Exchange Commission.

IncellDx said recently that that it has signed an agreement with Singapore-based Biolidics to distribute its IncellDx bioINK PD-L1 CTC Core Kit.

Biotia, a startup providing DNA sequencing-based microbial surveillance services and infectious disease diagnostic tests for hospitals, said recently that it has closed a $2.4 million seed financing round.